Adenosine vs Diltiazem for SVT in the emergency room
Part of Heart & circulation clinical trials.
This study compares two medications, adenosine and diltiazem, to see which works better for treating a rapid heart rhythm called SVT (supraventricular tachycardia) in the emergency department. If you have a stable episode of SVT, this trial may help doctors find the best treatment for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You are diagnosed with stable SVT (a fast heart rhythm) in the emergency department
- You have not received any IV heart rhythm medication for this episode before joining the study
- You do not have a history of Wolff-Parkinson-White syndrome (WPW, a specific heart condition)
- You do not have heart failure with a weak pump (ejection fraction less than or equal to 40%)
- You are not pregnant, not incarcerated, and have not been in this study before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares how patients feel about two common medicines (adenosine and diltiazem) used to treat a fast heart rhythm called SVT in the emergency department. If you were treated for SVT in the ER, you may be able to share your experience through a survey.
This trial compares two medicines, adenosine and verapamil, to see which works better for stopping a sudden fast heart rhythm called SVT. If you have an episode of SVT that is stable enough to not need emergency shock treatment, you may be able to join.
This trial tests two medicines — one taken by mouth (bisoprolol) and one given through an IV (diltiazem) — to see which is better at safely slowing a too-fast heartbeat in people with atrial fibrillation or flutter. If you have this heart rhythm problem with a fast rate and are otherwise stable, the study might help find the most effective way to bring your heart under control.
This study compares two medications, verapamil and metoprolol, given in the emergency department to slow down a fast, irregular heartbeat caused by atrial fibrillation. It aims to find which medicine works better and is safer for patients like you.
This study tests a treatment for supraventricular tachycardia (SVT), a condition where the heart beats too fast. It aims to see if the treatment is safe and works well in children.
This study compares two catheter-based procedures to treat ventricular tachycardia (VT), a fast, dangerous heart rhythm. It looks to see which approach works better at reducing repeat VT events in people with weakened heart pumping.
Hear when a new Supraventricular Tachycardia (SVT) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.